In this new blog post, Ontada's Chief Data Officer Amy Sheide, RN, and Head of Product Wesley Keller discuss the importance of building foundational data that is relevant, complete and clearly defined. While AI has made it technically possible to move faster, without a trusted data foundation it can accelerate uncertainty just as easily as analysis. Speed becomes more predictable when it is determined upstream, in whether the underlying data can be reused, explained and defended as scrutiny increases. Read more: https://lnkd.in/gRe8saAf
ISPOR 2026 begins tomorrow, and we can't wait to share some of our latest research: Monday, 5/18: 📌 Improving Real-World Adoption of HER2-Low Therapies Through Targeted Educational Initiatives 🗣️ Presenter: Jess Paulus 🕐 10:30 AM–1:30 PM 🔗 https://bit.ly/4d2hTcd 📌 Enhancing Real-World Data (RWD) Quality: Implementation of Regulatory Data Quality Framework Within a Large US Oncology Electronic Health Record (EHR)-Derived Database 🗣️ Presenter: Saamir Pasha 🕐 10:30 AM–1:30 PM 🔗 https://bit.ly/4t69YAs
WATCH: Dr. Ira Zackon, Ontada's Senior Medical Director, talks with the HealthTree Foundation about treatment patterns and outcomes in older acute myeloid leukemia (AML) patients, including how non-intensive therapies are affecting care and survival rates. This interview was conducted at ASH 2025. https://lnkd.in/giRBZTeS Interested in joining the Ontada team? Click here: https://www.ontada.com/company/careers/ #RWD #CommunityOncology
At Ontada, we’re advancing the future of cancer care—and conversations like this fuel our mission. In this OncoTalks episode from McKesson Accelerate 2025, Suzzette Arnal, PhD sits down with Dr. Melissa Johnson to explore how precision medicine and biomarker insights are reshaping treatment for non‑small cell lung cancer. They discuss the latest breakthroughs in targeted therapies, immunotherapies, and the growing impact of clinical trials. If you want to use data, science, and technology to make a meaningful impact in oncology, come build the future with us. 🔗 Watch the episode: https://lnkd.in/gB2j8Eb5 💼 Explore Ontada careers: https://www.ontada.com/company/careers/
Today is World Cancer Day. Behind every diagnosis is a unique person with their own story and needs. By empowering oncology breakthroughs with real-world data and research on social determinants of health (SDOH), we're helping to put individuals at the center of cancer care. #UnitedByUnique #RWD #SDOH #CancerCare #WorldCancerDay
Start 2026 with a new career! ✨ This season, resolve to find purpose in your work—and join a team that advances health outcomes for all. Explore careers at Ontada: https://www.ontada.com/company/careers/
This weekend, we'll be in Orlando, FL for the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. We're excited to share some of our latest research, including the analysis of real-world data related to treatments for chronic lymphocytic leukemia (CLL), multiple myeloma, and more. Learn about our poster presentations here: https://lnkd.in/gCHDw5Dg And don't forget to visit booth #106 to speak with us about our real-world oncology data, research offerings, and provider education solutions. 💡 Passionate about making a difference in cancer care? Explore career opportunities with Ontada today: https://www.ontada.com/company/careers/
Next week, Ontada will be in Glasgow, Scotland for ISPOR—The Professional Society for Health Economics and Outcomes Research Europe. If you're attending the event, we'd love to speak with you—stop by Booth #616 or schedule a time to meet with Jade Cusick and Jennifer Frytak, PhD, here: https://lnkd.in/gi45XPsM We're thrilled to share that we'll also be presenting five pieces of research at this year's conference, including one oral presentation and four poster presentations—details below: 🗣️ Oral Presentation 🗣️ ⭐ A Framework for Accelerating Clinical Development with Real-World External Control Arms (ECA) in Phase 2 Trials 👩🏫 Presented by: Jess Paulus, ScD 📌 Session Title: Leveraging Real-World Data in HTA 🗓️ Monday, November 10, 5:00-6:00 PM 🔗 https://bit.ly/3INctGD 📊 Poster Presentation 📊 🏆 Top 5% finalist for the ISPOR Europe 2025 Research Presentation Awards 🏆 ⭐ Real-World Associations between Smoking Status and Genetic Driver Mutations in Metastatic Lung Cancer in US Community Oncology 👩🏫 Presented by: Jess Paulus, ScD 📌 Poster Code: RWD148 🗓️ Tuesday, November 11, 4:00 PM - 7:00 PM (discussion period begins at 6:00 PM) 🔗 https://bit.ly/3WmXGFK And more!
Will you be at the Databricks Data + AI World Tour in Boston next week? If so, be sure to attend Zhaohui's session! #Ontada #AdvancingCancerCareThroughResearch
🔬 Advancing Cancer Care Through Research At #ASCO25, Ontada’s Alisha Kimble, PhD, MPH, shared groundbreaking insights on Waldenström macroglobulinemia (WM) in an interview with Cure (MJH Life Sciences®). Her work reflects Ontada’s commitment to transforming oncology through real-world evidence and innovation. 💡 Passionate about making a difference in cancer care? Explore career opportunities with Ontada: https://www.ontada.com/company/careers/
